Y. J. Bang, E. Van Cutsem, A. Feyereislova, H. C. Chung, L. Shen: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. In: The Lancet. 19. Aug 2010. PMID 20728210.